Friday, 23 Aug 2019

You are here

Kevin Winthrop, MD: H. zoster and tofacitinib: the risk of concomitant nonbiologic therapy

Dr. Kevin Winthrop, associate professor of infectious diseases at Oregon Health & Sciences University in Portland, Oregon, discusses abstract 559.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

RheumNow Live Preview with Dr. Philip...

15 Apr 2019

RheumNow Live Preview with Dr. Ronald...

08 May 2019

RheumNow Podcast – You Owe Me a DEXA (...

15 Mar 2019

Dr. Jack Cush: Fewer Rheumatologists (...

13 Nov 2016

RheumNow Week in Review - 3 June 2016

03 Jun 2016

Dr. Gregg Silverman: The Microbiome and...

05 Nov 2017

Dr. Richard Furie - Anifrolumabs...

29 Aug 2016

Dr. Ted Pincus - FAST3 A Novel...

10 Jul 2017

RheumNow Live Preview with Dr. Elaine...

29 Apr 2019

Dr. Sergio Schwartzman: uveitis

02 Mar 2016

RheumNow Week in Review – 22 July 2016

22 Jul 2016

Dr Jack Cush: Stills and Auto-...

08 Nov 2017